- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Low-grade Serous Ovarian Carcinoma in New Zealand
Total 1008 results
-
Marker Therapeutics, Inc.TerminatedOvarian Cancer | Platinum Sensitive Ovarian CancerUnited States
-
Tango Therapeutics, Inc.RecruitingBreast Cancer | Ovarian Cancer | Prostate Cancer | Pancreas Cancer | BRCA1 Mutation | BRCA-Mutated Ovarian Carcinoma | BRCA-Associated Breast Carcinoma | HRD Positive Advanced Ovarian CancerUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)Active, not recruitingMetastatic Melanoma | Advanced Malignant Solid Neoplasm | Unresectable Melanoma | Clinical Stage III Cutaneous Melanoma AJCC v8 | Pathologic Stage IIIB Cutaneous Melanoma AJCC v8 | Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 | Pathologic Stage IIID Cutaneous Melanoma AJCC v8 | Pathologic Stage... and other conditionsUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI); Incyte Corporation; Celldex TherapeuticsCompletedFallopian Tube Carcinoma | Ovarian Carcinoma | Primary Peritoneal CarcinomaUnited States
-
Ruhr University of BochumCompletedRecurrent Ovarian CancerGermany
-
National Cancer Institute (NCI)CompletedFallopian Tube Cancer | Primary Peritoneal Cavity Cancer | Recurrent Ovarian Epithelial CancerUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedEpithelial Ovarian CancerUnited States
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingOvarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Undifferentiated Carcinoma | Ovarian Mucinous Adenocarcinoma | Fallopian Tube Transitional Cell Carcinoma | Ovarian Transitional Cell Carcinoma | Fallopian Tube Endometrioid Adenocarcinoma | Fallopian Tube Mucinous Adenocarcinoma and other conditionsUnited States, Korea, Republic of, Canada
-
Daniela Matei, MDBayer; Hoosier Cancer Research NetworkTerminated
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)Terminated
-
amy tierstenAstraZeneca; Eisai Inc.CompletedRecurrent Ovarian Cancer | HER2-Negative Metastatic Breast CancerUnited States
-
Yale UniversityNational Cancer Institute (NCI); University of MiamiRecruiting
-
Roswell Park Cancer InstituteEisai Inc.CompletedRecurrent Ovarian Epithelial Cancer | Recurrent Primary Peritoneal Cavity Cancer | Recurrent Fallopian Tube CancerUnited States
-
Yale UniversityNational Cancer Institute (NCI)TerminatedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity CancerUnited States
-
MorphotekCompletedPeritoneal Neoplasms | Ovarian Cancer | Fallopian Tube CancerUnited States, Germany
-
CASI Pharmaceuticals, Inc.CompletedOvarian Cancer | Peritoneal Cancer | Fallopian CancerUnited States, Canada
-
Cordgenics, LLCActive, not recruitingRecurrent Ovarian Carcinoma | Platinum-resistant Ovarian CancerUnited States
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedBreast Carcinoma | Fallopian Tube Carcinoma | Ovarian Neoplasm | Primary Peritoneal CarcinomaUnited States
-
National Cancer Institute (NCI)TerminatedRecurrent Ovarian Epithelial Cancer | Recurrent Primary Peritoneal Cavity Cancer | Recurrent Fallopian Tube CancerUnited States
-
New Mexico Cancer Care AllianceNational Cancer Institute (NCI)CompletedCervical Cancer | Ovarian Epithelial Cancer | Uterine Sarcoma | Vulvar Cancer | Endometrial Cancer | Ovarian Germ Cell TumorUnited States
-
ImmunoGen, Inc.Gynecologic Oncology GroupCompletedOvarian Cancer | Fallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal CarcinomaUnited States, France, Canada, Spain, Switzerland, Belgium, Italy, United Kingdom, Ireland, Russian Federation, Bosnia and Herzegovina, Czechia, Serbia
-
Eleison Pharmaceuticals LLC.Terminated
-
MEI Pharma, Inc.CompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity CancerUnited States, Australia
-
Astellas Pharma IncOSI PharmaceuticalsCompletedOvarian NeoplasmsUnited Kingdom, United States
-
AstraZenecaCompletedRelapsed Ovarian Cancer, BRCA Mutation, Platinum SensitivityUnited States, Canada
-
Memorial Sloan Kettering Cancer CenterRecruiting
-
Dana-Farber Cancer InstituteNovartis; Pediatric Oncology Experimental Therapeutics Investigators' ConsortiumCompletedGlioma | Astrocytoma | Low-grade GliomaUnited States
-
Genentech, Inc.Completed
-
Duke UniversityAventis PharmaceuticalsCompletedOvarian CancerUnited States
-
PharmaMarCompletedOvarian CancerUnited States
-
Unither PharmaceuticalsTerminated
-
Gynecologic Oncology GroupNational Cancer Institute (NCI); Eastern Cooperative Oncology Group; Southwest... and other collaboratorsTerminated
-
National Cancer Institute (NCI)CompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cancer | Triple-Negative Breast Cancer | Serous Carcinoma CancerUnited States, Canada
-
AbbVie (prior sponsor, Abbott)Completed
-
National Cancer Institute (NCI)Active, not recruitingHIV Infection | Metastatic Renal Cell Carcinoma | Anatomic Stage III Breast Cancer AJCC v8 | Recurrent Ovarian Carcinoma | Metastatic Lung Non-Small Cell Carcinoma | Anatomic Stage IV Breast Cancer AJCC v8 | Metastatic Melanoma | Recurrent Head and Neck Carcinoma | Recurrent Renal Cell Carcinoma | Advanced... and other conditionsUnited States
-
Array Biopharma, now a wholly owned subsidiary...CompletedFallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal CancerUnited States
-
GlaxoSmithKlineCompletedOvarian Cancer | Fallopian Tube Cancer | Peritoneal Cancer | Neoplasms, OvarianUnited States, Australia, Singapore
-
Baylor College of MedicineMedical University of South Carolina; M.D. Anderson Cancer Center; The University... and other collaboratorsCompletedAnal High Grade Squamous Intraepithelial LesionUnited States
-
Reid Merryman, MDAbbVie; GenmabRecruitingFollicular Lymphoma | Low Grade Non-Hodgkin's Lymphoma, AdultUnited States
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)CompletedHigh Grade Upper Tract Urothelial CarcinomaUnited States
-
Northwell HealthKatie Oppo Research FundRecruitingOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CarcinomaUnited States
-
Mesoblast, Inc.Quintiles, Inc.CompletedGrade B Acute Graft Versus Host Disease | Grade C Acute Graft Versus Host Disease | Grade D Acute Graft Versus Host DiseaseUnited States
-
Gynecologic Oncology Trial & Investigation ConsortiumJapanese Gynecologic Oncology GroupCompletedFallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal CarcinomaJapan, United States, Hong Kong, Korea, Republic of, New Zealand, Singapore
-
New Mexico Cancer Care AllianceRecruitingOvarian CancerUnited States
-
Albert Einstein College of MedicineNational Cancer Institute (NCI)CompletedTreating Patients With Advanced Solid Tumors, Breast Cancer or Recurrent Ovarian Cancer (BMS-247550)Breast Cancer | Ovarian Cancer | Unspecified Adult Solid Tumor, Protocol SpecificUnited States
-
NRG OncologyNational Cancer Institute (NCI)RecruitingOvarian CarcinomaUnited States, Korea, Republic of
-
GlaxoSmithKlineCompletedOvarian Cancer | Neoplasms, OvarianUnited States, Canada
-
ImmunoVaccine Technologies, Inc. (IMV Inc.)TerminatedMaveropepimut-S (MVP-S) and Low-Dose CPA in Patients With Platinum-Resistant Ovarian Cancer (AVALON)Platinum-resistant Epithelial Ovarian CancerUnited States, Canada, Puerto Rico
-
University of Alabama at BirminghamChildren's Healthcare of Atlanta; Children's Hospital Los AngelesRecruiting
-
National Cancer Institute (NCI)CompletedFallopian Tube Cancer | Stage IV Breast Cancer | Stage IV Ovarian Epithelial Cancer | Recurrent Breast Cancer | Recurrent Ovarian Epithelial Cancer | Stage III Ovarian Epithelial Cancer | Female Reproductive CancerUnited States